| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/09/2000 | WO2000012493A1 Thiazoline acid derivatives |
| 03/09/2000 | WO2000012140A1 Method for labeling biopolymers using isotopes |
| 03/09/2000 | WO2000011943A1 Post-pubertary amygdala lesions as animals models for cns disorders |
| 03/09/2000 | CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 03/09/2000 | CA2337869A1 Method for labeling biopolymers using isotopes |
| 03/08/2000 | EP0983506A2 Functional expression of, and assay for, functional cellular receptors in vivo |
| 03/08/2000 | EP0983273A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 03/08/2000 | EP0983230A1 Yellow polymorph of 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihydroxypropyl)-isophthalamide |
| 03/08/2000 | EP0983105A1 Method of removing thrombosis in fistulae |
| 03/08/2000 | EP0755222A4 Microfluidization of calcium/oxyanion-containing particles |
| 03/08/2000 | EP0591355B1 Porphycene compounds for photodynamic therapy |
| 03/08/2000 | CN1246844A Process for preparation of iodinated contrast agents and intermediates |
| 03/07/2000 | US6034267 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 03/07/2000 | US6033646 Method of preparing fluorinated gas microspheres |
| 03/07/2000 | US6033645 Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 03/07/2000 | US6033644 Biomodulators as universal imaging agents |
| 03/02/2000 | WO2000011007A1 Carboxylated phosphatidic acid esters |
| 03/02/2000 | WO2000010579A1 Method for detection of biological factors in epidermis |
| 03/02/2000 | WO2000010577A1 Composition, method and apparatus for inducing controlled cognitive disorder |
| 03/02/2000 | WO2000010541A1 Stable spray-dried protein formulations |
| 03/02/2000 | WO1999064869A3 Back pain diagnosis and apparatus for use therein |
| 03/02/2000 | WO1999059640A3 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 03/02/2000 | WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 03/02/2000 | DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes |
| 03/02/2000 | CA2340673A1 Method for detection of biological factors in epidermis |
| 03/01/2000 | EP0981748A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/01/2000 | EP0981602A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 03/01/2000 | CN1246059A Polymers |
| 02/29/2000 | US6030841 Processing series of blood samples obtained at timed intervals after intravenous injection of colored/fluorescent bile acid derivative to obtain plasma, measuring color or fluorescence, fitting to plasma elimination curve, comparing |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030603 Emulsions as contrast agents and method of use |
| 02/29/2000 | CA2246204A1 Bipodal ligand-metal ion chelates |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/24/2000 | WO2000009670A1 Purified human papillomavirus |
| 02/24/2000 | WO2000009502A1 Fluorescent labelling reagents |
| 02/24/2000 | WO2000009170A1 Combination of a positive mri contrast agent with a negative mri contrast agent |
| 02/24/2000 | WO2000009169A1 Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical |
| 02/23/2000 | CN1245437A Method for detecting abnormal epithelial cell shedding |
| 02/23/2000 | CN1049583C Chinese medicine stomach ultrasonophy B developer and preparing process thereof |
| 02/22/2000 | US6028194 Intermediates |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028066 For delivering higher concentrations of bioactive agents to improve efficacy of the bioactive agents |
| 02/22/2000 | US6028056 Useful for in vivo detection and diagnosis of thrombi. the precursor reagents of the invention may also be used in production of antithrombotic agents derived from apcitide |
| 02/22/2000 | US6027946 Process and compounds for the magnetorelaxometric detection of analytes and use thereof |
| 02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
| 02/22/2000 | CA2164410C Emulsions as contrast agents and method of use |
| 02/22/2000 | CA2004532C Peptide derivatives |
| 02/17/2000 | WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007565A2 Methods of ophthalmic administration |
| 02/17/2000 | CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | CA2347906A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/16/2000 | EP0979298A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 02/16/2000 | EP0979107A1 Light imaging contrast agents |
| 02/16/2000 | EP0979104A1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 02/16/2000 | EP0979103A1 Compounds |
| 02/16/2000 | EP0979071A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 02/15/2000 | US6026317 Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists |
| 02/15/2000 | US6025475 Antibody |
| 02/15/2000 | US6024939 Contrast media for ultrasonic imaging |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | US6024707 Non-invasive method for diagnosing Alzheimer's disease in a patient |
| 02/15/2000 | US6024176 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 02/15/2000 | CA2132001C Methods of treating cancer using modified c-reactive protein |
| 02/15/2000 | CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques |
| 02/10/2000 | WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | WO2000006244A2 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| 02/10/2000 | WO2000006207A1 Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond |
| 02/10/2000 | WO2000006124A2 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 02/10/2000 | WO2000006014A1 Method for marking red blood cells using a water-soluble fluorescent colouring agent |
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999055837A3 Improvements in or relating to separation processes |
| 02/10/2000 | WO1999049899A3 Diagnostic imaging of vascular abnormalities using vasomodification |
| 02/10/2000 | CA2338702A1 Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond |
| 02/10/2000 | CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | CA2337320A1 Method for marking red blood cells using a water-soluble fluorescent colouring agent |
| 02/09/2000 | EP0978282A2 Sublingual composition containing apomorphine for diagnosing functional impotence |
| 02/09/2000 | EP0977864A2 Antigenic composition and method of detection for helicobacter pylori |
| 02/09/2000 | EP0977815A1 ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND $i(IN VIVO) IMAGING AND PREVENTION OF AMYLOID DEPOSITION |
| 02/09/2000 | EP0977600A2 Contrast agents |
| 02/09/2000 | EP0977599A1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations |
| 02/09/2000 | EP0977598A1 Nmr image compounds |
| 02/09/2000 | EP0977597A4 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 02/09/2000 | EP0977597A1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 02/09/2000 | EP0977594A1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | CN1244131A Contrast agents containing two types of gas filled microbubbles |
| 02/09/2000 | CN1243753A Contrast medium for ultrasonic diagnosis and its preparing process |
| 02/08/2000 | US6022981 Key intermediates in synthesizing 5,10-disubstituted porphyrin compounds or other 5,10-disubstituted polypyrrolic macrocycles. |
| 02/08/2000 | US6022966 Conjugate comprises a dota chelate component, a biotin component and a linker component resistant to biotinidase cleavage |
| 02/08/2000 | US6022526 Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma |
| 02/08/2000 | US6022525 Preparation of diagnostic agents |
| 02/08/2000 | US6022524 Conjugating amino groups of macromolecules with activated polycarboxylic chelants; removing unreacted chelant, forming metal complex of conjugate, reacting complex with chelant and again complexing with metal; high content of chelants groups |
| 02/08/2000 | US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 02/08/2000 | US6022522 Rigid bifunctional chelating agents |
| 02/08/2000 | CA2095832C Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |